DBV Technologies (DBVT) Short term Debt (2015 - 2020)
DBV Technologies (DBVT) posted quarterly Short term Debt of $665703.2 for Q2 2020, up 2.27% year-on-year from $650909.8 in Q3 2019, and up 1.39% on a QoQ basis from $656599.6 in Q4 2019.
DBV Technologies (DBVT) Short term Debt (2015 - 2020) Analysis & Trends
DBV Technologies (DBVT) has reported Short term Debt for 6 consecutive years, with $665703.2 the latest figure, recorded in Q2 2020.
- Quarterly Short term Debt rose 2.27% year-over-year to $665703.2 in Q2 2020, while the trailing twelve-month figure through Jun 2020 was $665703.2 (up 2.27% YoY) and the FY2019 annual result came in at $656599.6, down 51.96% from the prior year.
- Short term Debt grew to $665703.2 in Q2 2020 per DBVT's latest filing, from $656599.6 in the prior quarter.
- Over the last five years, Short term Debt for DBVT reached as high as $3.4 million in Q4 2017 and fell as low as $650909.8 in Q2 2019.
- A 5-year average of $1.3 million and a median of $759320.1 in 2016 frame the typical range for Short term Debt.
- Annual changes were most pronounced in 2016 — Short term Debt jumped 296.64% — and 2018, when it tumbled 59.27%.
- Year by year, Short term Debt stood at $852936.9 in 2016, then surged by 293.4% to $3.4 million in 2017, then slumped by 59.27% to $1.4 million in 2018, then slumped by 51.96% to $656599.6 in 2019, then grew by 1.39% to $665703.2 in 2020.
- According to Business Quant data, Short term Debt over the past three periods registered $665703.2, $656599.6, and $650909.8 for Q2 2020, Q4 2019, and Q2 2019 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | DBV Technologies | 267.50 Mn | 92.60 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | 665,703.25 |
| Dec 31, 2019 | 656,599.61 |
| Jun 30, 2019 | 650,909.84 |
| Dec 31, 2018 | 1.37 Mn |
| Dec 31, 2017 | 3.36 Mn |
| Dec 31, 2016 | 852,936.93 |
| Dec 31, 2015 | 215,038.24 |